These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 23076480

  • 1. [Early insulin therapy in type 2 diabetes?].
    Birkeland KI.
    Tidsskr Nor Laegeforen; 2012 Oct 16; 132(19):2151-2. PubMed ID: 23076480
    [No Abstract] [Full Text] [Related]

  • 2. Comments on ORIGIN trial.
    Mazzucchelli C, Bordone C, Maggi D, Cordera R.
    Nutr Metab Cardiovasc Dis; 2013 Aug 16; 23(8):e33-4. PubMed ID: 23786822
    [No Abstract] [Full Text] [Related]

  • 3. ORIGIN trial shows safety and efficacy of insulin glargine: no adverse cardiovascular outcomes after a 6.2-year follow up of early insulin use.
    Lombard L, Distiller L, Aalbers J.
    Cardiovasc J Afr; 2012 Jul 16; 23(6):357-8. PubMed ID: 23091824
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Basal insulin and cardiovascular and other outcomes.
    Schernthaner G, Currie CJ.
    N Engl J Med; 2012 Nov 01; 367(18):1762; author reply 1763-4. PubMed ID: 23113495
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. N-3 fatty acids did not reduce major cardiovascular events in patients with dysglycaemia.
    Kromhout D.
    Evid Based Med; 2013 Aug 01; 18(4):e34. PubMed ID: 23173155
    [No Abstract] [Full Text] [Related]

  • 12. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved glycaemic control with no weight gain: a 26-week, open label, non-randomised, non-interventional observational study on type 2 diabetes subjects using insulin detemir.
    Tripathi S, Chandalia HB, Rao PV, Badgandi M, Patni R, Subbanna PK, Shetty R, Kumar H.
    J Indian Med Assoc; 2011 Apr 03; 109(4):275-8. PubMed ID: 22187803
    [Abstract] [Full Text] [Related]

  • 18. Lessons from glargine trials: what is the goal fasting glucose with basal insulin?
    Bloomgarden Z, Handelsman Y.
    J Diabetes; 2014 Jul 03; 6(4):271-3. PubMed ID: 24656089
    [No Abstract] [Full Text] [Related]

  • 19. Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results.
    Bolli GB, Consoli A, Giaccari A.
    Nutr Metab Cardiovasc Dis; 2012 Dec 03; 22(12):1007-12. PubMed ID: 23199612
    [Abstract] [Full Text] [Related]

  • 20. [Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
    Rausch R.
    Med Monatsschr Pharm; 2014 Jul 03; 37(7):273-4. PubMed ID: 25065174
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.